Lantidra Chronology: 19 Years From IND Submission To Approval For The Cellular Therapy

 
• By Sue Sutter

Pink Sheet’s Drug Review Profile looks at the timeline behind the development and FDA review of CellTrans’ treatment for type 1 diabetes.

Drug Review Profile: Lantidra Chronology
• Source: Pink Sheet/Shutterstock

More from Drug Review Profiles

More from Product Reviews